|
|
|
|
| LEADER |
01861nam a2200253Ia 4500 |
| 001 |
10.3233-SHTI220740 |
| 008 |
220718s2022 CNT 000 0 und d |
| 020 |
|
|
|a 18798365 (ISSN)
|
| 245 |
1 |
0 |
|a Clinical Trials on Alternative Medicines for COVID-19
|
| 260 |
|
0 |
|b NLM (Medline)
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3233/SHTI220740
|
| 520 |
3 |
|
|a In this study, we addressed the alternative medications that have been targeted in the clinical trials (CTs) to be evidenced as an adjuvant treatment against COVID-19. Based on the outcomes from CTs, we found that dietary supplements such as Lactoferrin, and Probiotics (as SivoMixx) can play a role enhancing the immunity thus can be used as prophylactics against COVID-19 infection. Vitamin D was proven as an effective adjuvant treatment against COVID-19, while Vitamin C role is uncertain and needs more investigation. Herbals such as Guduchi Ghan Vati can be used as prophylactic, while Resveratrol can be used to reduce the hospitalization risk of COVID-19 patients. On the contrary, there were no clinical improvements demonstrated when using Cannabidiol. This study is a part of a two-phase research study. In the first phase, we gathered evidence-based information on alternative therapeutics for COVID-19 that are under CT. In the second phase, we plan to build a mobile health application that will provide evidence based alternative therapy information to health consumers.
|
| 650 |
0 |
4 |
|a Alternative medicine
|
| 650 |
0 |
4 |
|a Clinical trial
|
| 650 |
0 |
4 |
|a Coronavirus
|
| 650 |
0 |
4 |
|a COVID-19
|
| 700 |
1 |
|
|a Abd-Alrazaq, A.
|e author
|
| 700 |
1 |
|
|a Alam, T.
|e author
|
| 700 |
1 |
|
|a Househ, M.
|e author
|
| 700 |
1 |
|
|a Jaber, B.A.
|e author
|
| 700 |
1 |
|
|a Qureshi, R.
|e author
|
| 700 |
1 |
|
|a Rahman, M.A.
|e author
|
| 700 |
1 |
|
|a Shah, Z.
|e author
|
| 773 |
|
|
|t Studies in health technology and informatics
|
